Results 171 to 180 of about 323,821 (301)

Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system. [PDF]

Medicine (Baltimore)
Huang X, Chen Y, Li S, Wen Y, Liu H, Cao G.   +5 more
europepmc   +1 more source

Validity and reliability of Insomnia Severity Index among older adults in Indonesia. [PDF]

PeerJ
Kemala Sari N, Stepvia S, Ilyas MF.
europepmc   +1 more source

Diurnal‐Only Foslevodopa/Foscarbidopa

Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin, Yu‐Yan Poon, Galit Kleiner, Alfonso Fasano   +3 more
wiley   +1 more source

Depressive symptoms in people with late effects of polio and the association with sociodemographic and disability‐related factors

PM&R, EarlyView.
Abstract Background Late effects of polio (LEoP) is a progressive condition leading to a lifelong disability that can affect mental health. There is limited knowledge of depressive symptoms and associated factors in people with LEoP. Objective To assess the occurrence of depressive symptoms in people with LEoP and explore the association with ...
Maria Nolvi, Christina Brogårdh, Lars Jacobsson, Jan Lexell   +3 more
wiley   +1 more source

Insomnia, sleep duration and incident Parkinson's disease in the Finnish population cohort. [PDF]

Brain Commun
Sulkava S, Kantojärvi K, Haukka J, Paunio T.   +3 more
europepmc   +1 more source

Accelerating the prioritisation of plant species with underexplored medicinal potential: The pm4mp (Phylogenetic Methods for Medicinal Plants) R package

PLANTS, PEOPLE, PLANET, EarlyView.
Medicinal plants used in ethnobotanical traditions to treat or prevent diseases have gained renewed interest for their largely untapped potential in drug discovery. In this study, we developed and tested novel methods to prioritise plant species based on their unexplored medicinal potential. By enabling researchers to target the most promising species,
Giovanni Zecca, Elisa Toini, Massimo Labra, Fabrizio Grassi   +3 more
wiley   +1 more source

Phenotypic Clues in Infantile‐Onset Parkinsonism‐Dystonia‐2: A Treatable Neurotransmitter Disorder

Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan, Haya S. AlFaris, Lindsey Vogt, Michele Eid, Anika Menetrey, Sayoni Roy Chowdhury, Dawn Codeiro, Pradeep Krishnan, Liali Aljouda, Emily W.Y. Tam, Carolina Gorodetsky   +10 more
wiley   +1 more source

Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review

Phytotherapy Research, EarlyView.
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley   +1 more source

Prevalence and influencing factors of insomnia in patients with coronary heart disease: a systematic review and meta-analysis. [PDF]

Front Psychiatry
Liu SL, Chen Y, Bai XD, Xu T, Xu HY, Lin SY, Zhou XY, Jiang YL.   +7 more
europepmc   +1 more source

Treating insomnia [PDF]

BMJ, 2004
openaire   +2 more sources